600 patients66,869 observations120 daysLIVE

Patient P-01440

Synthetic patientNBL-101 · Day 115 · 45–54 · M · baseline S12Steering view · 3DOpen companion preview
Therapy response
Stable
Tolerance
Stable
GI state
Unstable
Inflammatory state
Unstable
Nutritional resilience
Unstable
Discontinuation risk
71%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 startedBaseline state S12
  2. Day 49 Trajectory diverged from predictionObserved response fell below the model's expected path.
  3. Day 52 GI-04 recommendedGI Support Protocol GI-04
  4. Day 53 Patient acceptedStarted GI-04 in the companion
  5. Day 61 No meaningful changeGI Support Protocol GI-04

What changed?

Trajectory began diverging from predicted response on Day 49.

Primary contributors, last 14 days
  • Nutritional resilience+7
  • Treatment adherence+6
  • Toxicity+4
  • GI instability-2
  • Inflammatory activity-2

What helped?

  • GI Support Protocol GI-04Day 52
    Result: no meaningful change
LIFE OS recommendation
Dietary Support Protocol NP-02
61%
probability of meaningful tolerance improvement
  • 284 similar trajectories
  • 66% showed improvement
  • median effect visible after 10 days

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden
Companion
71.5/100
improving · -7.5 vs previous 14 d
Toxicity
Blood
55.5/100
worsening · +6.0 vs previous 14 d
Sleep quality
Wearable
11.9/100
improving · +5.1 vs previous 14 d
Energy level
Daily log
2.1/10
improving · +0.4 vs previous 14 d
Stress level
Daily log
7/10
improving · -0.6 vs previous 14 d
Steps
Wearable
3,470
stable · +132 vs previous 14 d
Adherence
Companion
46.6 %
improving · +4.1 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →

Heading drifting · 28 from the failing basin, 77 from restoration.

Would help
  • ME-01 Monitoring Escalation
    100% improved among 77 similar · onset 3 d · confidence 75%
  • NP-02 Dietary Support Protocol
    63% improved among 64 similar · onset 10 d · confidence 75%
  • SC-12 Supportive Compound
    76% improved among 51 similar · onset 6 d · confidence 75%
Would not help
  • GI-04 GI Support Protocol
    already tried, no meaningful change
  • Keep histamine low
    GI +3.2 next day on high-intake days · n 20
  • Keep simple carbs low
    GI +3.1 next day on high-intake days · n 12
  • Keep fat low
    GI +2.5 next day on high-intake days · n 16
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Histamine load
    +3.2detractor · 95%
  • Simple carbohydrates
    +3.1detractor · 95%
  • Dietary fat load
    +2.5detractor · 84%
  • Insoluble fibre
    -1.3no signal · 42%
  • Alcohol
    +1.3no signal · 42%
  • Spicy / capsaicin
    -0.9no signal · 26%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Autonomic recovery 65
    • WearableResting HR 74 bpm
    • Wearable3,470 steps/day
    • WearableShort sleep window
  • Mucosal barrier integrity 60
    • DNAFUT2 non-secretor lowers mucosal fucosylation
    • Daily logGI symptom score 72 and rising
    • WearableSleep 5.1 h, below personal baseline
  • Inflammatory signalling 60
    • MicrobiomeBacteroides fragilis expansion
    • BloodInflammatory load index 70
    • WearableHRV 31 ms, trending down
  • Drug metabolism and exposure 60
    • DNACYP2D6 poor metabolizer → higher exposure
    • BloodToxicity index 56
  • Butyrate / short-chain fatty acid production 20
    • Daily logFibre intake low in recent food logs
DNA
Fictional pharmacogenomic panel
  • FUT2 rs601338 AA (non-secretor)
    Reduced mucosal fucosylation
  • CYP2D6 Poor metabolizer
    Higher exposure at standard dose
Microbiome
Shannon diversity 2.6 · butyrate capacity 45/100
  • Akkermansia muciniphilaNormal
  • Faecalibacterium prausnitziiNormal
  • Bacteroides fragilisHigh
  • Bifidobacterium longumLow
  • EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
HRV
30 ms
Sleep
5.4 h
Steps
3,689
Resting HR
72 bpm
Daily log: GI score 72, nutritional resilience 37, adherence 47.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
  • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
  • Track each bowel movement today: time, stool form, urgency, overnight waking
  • A 15-minute walk after lunch
  • Protect a 7.5-hour sleep window; screens off 30 minutes before
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the scheduled dose as agreed with your care team
  • Electrolyte solution, one sachet after any loose stool
  • Fictional demo item: oral nutrition supplement with lunch

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0177253%S20NP-02no change50
P-0136750%S14GI-04no change51
P-0173650%S03ME-01improved46
P-0158249%S14GI-04no change45
P-0165248%S12ME-01improved44
P-0183048%S1444
P-0184148%S1448
P-0161547%S14ME-01improved48
P-0172847%S14SC-12improved41
P-0153146%S14ME-01improved51
P-0177646%S16NP-02no change47
P-0157245%S14GI-04worsened41